Literature DB >> 23312686

Is melatonin synthesis a new biomarker for the pathogenesis and treatment of phenylketonuria?

Stephen Cederbaum, Harvey L Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23312686      PMCID： PMC4327885          DOI： 10.1016/j.jpeds.2012.11.079

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function.

Authors:  J J Baskett; J F Cockrem; T A Antunovich
Journal:  J Pineal Res       Date:  1998-01       Impact factor: 13.007

Review 2.  Phenylketonuria: epitome of human biochemical genetics (first of two parts).

Authors:  C R Scriver; C L Clow
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

Review 3.  Up to date knowledge on different treatment strategies for phenylketonuria.

Authors:  Amaya Bélanger-Quintana; Alberto Burlina; Cary O Harding; Ania C Muntau
Journal:  Mol Genet Metab       Date:  2011-08-16       Impact factor: 4.797

Review 4.  Dopamine precursors and brain function in phenylalanine hydroxylase deficiency.

Authors:  H C Lou
Journal:  Acta Paediatr Suppl       Date:  1994-12

5.  Large neutral amino acid supplementation increases melatonin synthesis in phenylketonuria: a new biomarker.

Authors:  Shoji Yano; Kathryn Moseley; Colleen Azen
Journal:  J Pediatr       Date:  2012-11-16       Impact factor: 4.406
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.